title: Current understanding and treatment of headache disorders: five new things.
authors.affiliation: Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. michael.marmura@jefferson.edu
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Marmura
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Silberstein
mesh_terms: D001381:Azepines / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D002561:Cerebrovascular Disorders / Q000209:etiology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008881:Migraine Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use; D020795:Photophobia / Q000209:etiology
chemical_list: D001381:Azepines; D000077221:Calcitonin Gene-Related Peptide Receptor Antagonists; D007093:Imidazoles; D009465:Neuromuscular Agents; C525458:telcagepant; D019274:Botulinum Toxins, Type A